US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NVIDIA Portfolio

1,794.63

-154.1749-7.91%

Number of Gainers:- -

Number of Losers:8

Number of Flat:- -

PE:- -

High:1,938.06

Open:1,938.06

Low:1,749.72

Close:1,948.80

Loading ...

Recursion Pharmaceuticals Reports Mixed 2024 Financial Results

SoundHound AI Reports Strong Growth Amid Challenges

Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today

Recursion Pharmaceuticals Is Maintained at Market Perform by Leerink Partners

Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration

Arima Real Estate SOCIMI SA Outlines Director Remuneration Policy

Recursion Pharmaceuticals (RXRX) Gets a Hold from TD Cowen

Serve Robotics Inc. (SERV): A Bull Case Theory

Applied Digital Corp call volume above normal and directionally bullish

Recursion Pharma Shares Drop After Wider-Than-Expected 4Q Loss

BUZZ-Nvidia-backed Recursion Pharmaceuticals falls on bigger-than-expected Q4 loss

SoundHound AI Shares up 3.1% After Q4 Results

THOMSON REUTERS

Recursion Pharmaceuticals Shares Slide 10% After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS

Recursion Pharmaceuticals Shares Slide 12.3% Premarket After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS

Serve Robotics to Present at Cantor Global Technology Conference

BUZZ-SoundHound AI rises after Q4 rev beat-and-raise

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4609/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4609"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","market":"US","secType":"PLATE","nameCN":"NVIDIA Portfolio","latestPrice":1794.63,"timestamp":1741636799999,"preClose":1948.8049,"halted":0,"volume":115159046,"delay":0,"changeRate":-0.079113,"change":-154.174927,"pbRate":13.11498,"amount":1939850564.013048,"amplitude":0.096641,"prevYearClose":2189.1055,"fiveDayClose":1924.5844,"twentyDayClose":2593.086,"turnoverRate":0.090506,"marketCap":141166595584,"floatMarketCap":26844528384,"peRate":-108.333967},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","high":1938.0576,"amplitude":0.096641,"preClose":1948.8049,"low":1749.7235,"pbRate":"13.11498","latestPrice":1794.63,"volume":115159046,"delay":0,"open":1938.0576,"prevYearClose":2189.1055,"prevWeekClose":1948.8049,"prevMonthClose":2124.3938,"prevQuarterClose":2189.1055,"fiveDayClose":1924.5844,"twentyDayClose":2593.086,"sixtyDayClose":2328.5637,"secType":"PLATE","market":"US","turnoverRate":0.090506,"peRate":-108.333967,"marketCap":141166595584,"floatMarketCap":26844528384,"timestamp":1741636799999,"nameCN":"NVIDIA Portfolio"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4609\",,,,undefined,":{"bkCode":"BK4609","up":0,"down":8,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4609\",pageSize:16,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516538581","title":"Recursion Pharmaceuticals Reports Mixed 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2516538581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516538581?lang=en_us&edition=fundamental","pubTime":"2025-03-01 12:10","pubTimestamp":1740802200,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc ( ($RXRX) ) has released its Q4 earnings. Here is a breakdown of the information Recursion Pharmaceuticals, Inc pres...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-pharmaceuticals-reports-mixed-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-pharmaceuticals-reports-mixed-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4539","BK4609","BK4139","BK4548"],"gpt_icon":0},{"id":"2516895581","title":"SoundHound AI Reports Strong Growth Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2516895581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516895581?lang=en_us&edition=fundamental","pubTime":"2025-03-01 09:17","pubTimestamp":1740791824,"startTime":"0","endTime":"0","summary":"SoundHound AI, Inc Class A (($SOUN)) has held its Q4 earnings call. Read on for the main highlights of the call. SoundHound AI, Inc. recently held ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/soundhound-ai-reports-strong-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/soundhound-ai-reports-strong-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4587","BK4547","BK4609","BK4023","SOUN","BK4608"],"gpt_icon":0},{"id":"2516589196","title":"Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today","url":"https://stock-news.laohu8.com/highlight/detail?id=2516589196","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516589196?lang=en_us&edition=fundamental","pubTime":"2025-03-01 09:05","pubTimestamp":1740791111,"startTime":"0","endTime":"0","summary":"20:04 EST Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals (RXRX) today Published first on TheFly – the ultimate source f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-653k-shares-of-recursion-pharmaceuticals-today-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-653k-shares-of-recursion-pharmaceuticals-today-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4544","BK4609","ARKK","BK4585","RXRX","BK4539","BK4588","BK4548"],"gpt_icon":0},{"id":"2516030248","title":"Recursion Pharmaceuticals Is Maintained at Market Perform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2516030248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516030248?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:42","pubTimestamp":1740778920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 28, 2025 16:42 ET (21:42 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"510abd3fed60ede9221497638d602631","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RXRX","BK4548","BK4609","BK4139"],"gpt_icon":0},{"id":"2516730639","title":"Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2516730639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516730639?lang=en_us&edition=fundamental","pubTime":"2025-03-01 04:05","pubTimestamp":1740773128,"startTime":"0","endTime":"0","summary":"Analyst Gil Blum of Needham maintained a Buy rating on Recursion Pharmaceuticals (RXRX – Research Report), retaining the price target of $11.00. Gi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strong-buy-recommendation-for-recursion-pharmaceuticals-leading-techbio-innovator-with-robust-financials-and-strategic-ai-integration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strong-buy-recommendation-for-recursion-pharmaceuticals-leading-techbio-innovator-with-robust-financials-and-strategic-ai-integration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4139","BK4609","BK4539","RXRX"],"gpt_icon":0},{"id":"2516303231","title":"Arima Real Estate SOCIMI SA Outlines Director Remuneration Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2516303231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516303231?lang=en_us&edition=fundamental","pubTime":"2025-03-01 03:08","pubTimestamp":1740769721,"startTime":"0","endTime":"0","summary":"Arima Real Estate SOCIMI SA ( ($ES:ARM) ) just unveiled an announcement. Arima Real Estate SOCIMI SA has outlined its remuneration policy for direc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arima-real-estate-socimi-sa-outlines-director-remuneration-policy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arima-real-estate-socimi-sa-outlines-director-remuneration-policy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4609","BK4543","IE00BMPRXN33.USD","BK4588","BK4141","IE00BMPRXQ63.HKD","ARM","IE00BMPRXR70.SGD","BK4585","LU0348723411.USD"],"gpt_icon":0},{"id":"2516861303","title":"Recursion Pharmaceuticals (RXRX) Gets a Hold from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2516861303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516861303?lang=en_us&edition=fundamental","pubTime":"2025-03-01 02:45","pubTimestamp":1740768342,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Brendan Smith maintained a Hold rating on Recursion Pharmaceuticals (RXRX – Research Report) today. The company’s shares opened to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/recursion-pharmaceuticals-rxrx-gets-a-hold-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/recursion-pharmaceuticals-rxrx-gets-a-hold-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4539","BK4127","BK4139","BK4609","BK4207","BK4585","BK4548","TD","COWN","BK4566"],"gpt_icon":0},{"id":"2516381379","title":"Serve Robotics Inc. (SERV): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2516381379","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516381379?lang=en_us&edition=fundamental","pubTime":"2025-02-28 23:37","pubTimestamp":1740757030,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Serve Robotics Inc.  on Value Investing Subreddit Page by msrichson. In this article, we will summarize the bulls’ thesis on SERV. Serve Robotics Inc. 's share was trading at $8.72 as of Feb 27th.Serve Robotics  was originally the robotics division of Postmates before becoming an independent company in 2021 following Uber’s acquisition of Postmates. Uber remains a shareholder and utilizes SERV’s autonomous delivery robots for last-mile Uber Eats deliveries in Los Angeles. Customers have the option to use these robots for a lower delivery fee, and SERV is now scaling its fleet to 2,000 robots by year-end while expanding into Austin, TX.With 59 active robots operating 465 daily hours, SERV generated $112,288 in quarterly revenue, equating to $241 per robot hour. If SERV successfully scales to 2,000 robots with 50% uptime, it would result in 1,000 daily active robots operating 7,800 hours per day, translating to a projected quarterly revenue of $169.2 mill","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/serve-robotics-inc-serv-bull-153710735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999014906.USD","LU0006306889.USD","LU1983260115.SGD","BK4230","LU0353189763.USD","BK4209","BK4535","LU2264538146.SGD","BK4585","LU1988902786.USD","SGXZ31699556.SGD","LU1316542783.SGD","SG9999018857.SGD","SG9999014880.SGD","IE00B19Z3581.USD","SG9999015978.USD","LU1814569148.SGD","SG9999015952.SGD","LU1861214812.USD","BK4503","SG9999017495.SGD","BK4609","LU1861219969.SGD","SG9999018865.SGD","LU0106261372.USD","SG9999015986.USD","IE00BZ199S13.USD","BK4550","LU2360107325.USD","LU0082616367.USD","BK4505","LU0719512351.SGD","UBER","BK4022","GB00BDT5M118.USD","LU0127658192.USD","IE00B7SZLL34.SGD","BK4588","SG9999014914.USD","BK4551","LU2087625088.SGD","IE0002270589.USD","LU0353189680.USD","BK4604","SG9999015945.SGD","IE00B19Z3B42.SGD","LU0642271901.SGD","SERV","BK4536","SG9999014898.SGD"],"gpt_icon":1},{"id":"2514837591","title":"Applied Digital Corp call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2514837591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514837591?lang=en_us&edition=fundamental","pubTime":"2025-02-28 23:25","pubTimestamp":1740756309,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Applied Digital (APLD) Corp with 14,222 calls trading, 1.1x expected, and implied vol increasing almost 2 points to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/applied-digital-corp-call-volume-above-normal-and-directionally-bullish-19?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/applied-digital-corp-call-volume-above-normal-and-directionally-bullish-19?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4116","BK4609","BK4023","APLD","BK4608"],"gpt_icon":0},{"id":"2514837311","title":"Recursion Pharma Shares Drop After Wider-Than-Expected 4Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514837311","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514837311?lang=en_us&edition=fundamental","pubTime":"2025-02-28 23:09","pubTimestamp":1740755340,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals shares were down 7% to $7.12 after the company reported a fourth-quarter loss that was wider than analysts expected.The clinical-stage biotechnology company said it had a quarterly loss of $178.9 million, or 53 cents a share, compared with a loss of $93 million, or 42 cents a share, in the same quarter a year prior. Analysts polled by FactSet were looking for a loss of $124.8 million, or 41 cents a share.Revenue for the quarter was $4.55 million, compared with last year's $10.9 million and the $15.3 million analysts were expecting.The company said that for the fourth quarter, the decrease of revenue compared to the prior period was due to the timing of projects from its collaboration with Roche and Genentech.Recursion had a cash position of $603 million as of Dec. 31, compared with $401.4 million as of Dec. 31, 2023. On a combined basis, Recursion expects its cash runway to extend into 2027.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4139","RXRX","BK4609","BK4539"],"gpt_icon":1},{"id":"2514320925","title":"BUZZ-Nvidia-backed Recursion Pharmaceuticals falls on bigger-than-expected Q4 loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514320925?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:41","pubTimestamp":1740753671,"startTime":"0","endTime":"0","summary":"BUZZ-Nvidia-backed Recursion Pharmaceuticals falls on bigger-than-expected Q4 loss** Shares of Nvidia-backed AI drug developer Recursion Pharmaceuticals RXRX.O fall 13% to $6.67 premarket** The company posts Q4 revenue of $4.5 million, missing analysts' estimate of $19 million, according to data compiled by LSEG ** Reports Q4 net loss of 53 cents per share versus a loss estimate of 43 cents per share** Recursion wants to be the Amazon Prime of pharma by adopting a subscription model for selling its pipeline of medicines, Bloomberg reports** The company files for stock offering of up to $500 million - filing** It has ~390 mln outstanding shares, with a market capitalization of $3 bln, according to data compiled by LSEG** RXRX has fallen ~51% in the last 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ14I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD3.UK","LU2237957902.USD","NVDY","LU1868836591.USD","LU0957791311.USD","LU1718418525.SGD","LU0289739343.SGD","LU1066051498.USD","NVDS.UK","LU0215105999.USD","LU0823434740.USD","2NVD.UK","LU0154236417.USD","IE00B1XK9C88.USD","SG9999015978.USD","SG9999002232.USD","LU2471134879.HKD","LU0234572021.USD","LU0466842654.USD","BK4609","NVDD","RXRX","NVDS","IE00BKDWB100.SGD","NVDU","LU0265550359.USD","LU2077746001.SGD","NVD2.UK","LU0354030511.USD","LU1852331112.SGD","NVDX","BK4554","LU2065169927.USD","IE00BMPRXN33.USD","LU0080751232.USD","LU0056508442.USD","NVD","LU1267930730.SGD","SNVD.UK","LU1571399168.USD","LU2125909247.SGD","LU2125909916.SGD","LU2463028550.USD","NVIW.SI","3NVD.UK","BK4549","SG9999015952.SGD","LU2506951792.HKD"],"gpt_icon":1},{"id":"2514320578","title":"SoundHound AI Shares up 3.1% After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514320578?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:37","pubTimestamp":1740753469,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ1BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","BK4587","SOUN","BK4609","BK4608","BK4547"],"gpt_icon":0},{"id":"2514899320","title":"Recursion Pharmaceuticals Shares Slide 10% After Bigger-Than-Expected Q4 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514899320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514899320?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:32","pubTimestamp":1740753175,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0XB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4609","BK4548","BK4539","BK4139"],"gpt_icon":0},{"id":"2514321647","title":"Recursion Pharmaceuticals Shares Slide 12.3% Premarket After Bigger-Than-Expected Q4 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321647?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:21","pubTimestamp":1740748875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0RN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4609","BK4539","BK4548","RXRX"],"gpt_icon":0},{"id":"2514329192","title":"Serve Robotics to Present at Cantor Global Technology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2514329192","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514329192?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Feb. 28, 2025  -- Serve Robotics , a leading autonomous sidewalk delivery company, today announced that its Chief Financial Officer Brian Read will participate in a fireside chat at the Cantor Global Technology Conference on March 11, 2025, at 3:40 pm Eastern Time.Serve Robotics develops advanced, AI-powered, low-emissions sidewalk delivery robots that endeavor to make delivery sustainable and economical. Spun off from Uber in 2021 as an independent company, Serve has completed tens of thousands of deliveries for enterprise partners such as Uber Eats and 7-Eleven. Serve has scalable multi-year contracts, including a signed agreement to deploy up to 2,000 delivery robots on the Uber Eats platform across multiple U.S. markets.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/serve-robotics-present-cantor-global-130000480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999014906.USD","IE00B19Z3B42.SGD","LU0006306889.USD","LU0106261372.USD","BK4536","IE0002270589.USD","IE00BZ199S13.USD","BK4535","SG9999015986.USD","BK4022","LU2087625088.SGD","SG9999014914.USD","SG9999015945.SGD","BK4550","SG9999018857.SGD","LU1983260115.SGD","LU1988902786.USD","LU2360107325.USD","BK4230","SG9999015978.USD","SG9999015952.SGD","LU1814569148.SGD","LU1861219969.SGD","IE00B19Z3581.USD","LU0642271901.SGD","BK4604","BK4609","SG9999017495.SGD","SG9999014898.SGD","SG9999018865.SGD","BK4585","LU1316542783.SGD","BK4588","LU0353189763.USD","LU0719512351.SGD","GB00BDT5M118.USD","SG9999014880.SGD","SERV","LU0127658192.USD","LU0353189680.USD","LU1064131342.USD","LU2264538146.SGD","IE00B7SZLL34.SGD","BK4505","SGXZ31699556.SGD","BK4209","BK4503","LU1861214812.USD","LU0082616367.USD"],"gpt_icon":1},{"id":"2514326545","title":"BUZZ-SoundHound AI rises after Q4 rev beat-and-raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326545?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:42","pubTimestamp":1740746554,"startTime":"0","endTime":"0","summary":"BUZZ-SoundHound AI rises after Q4 rev beat-and-raise** Shares of SoundHound AI SOUN.O up 3.3% to $9.51 ahead of the bell after qtrly rev topped analysts' expectations and it boosted 2025 rev outlook** Santa Clara, California-based co late Thurs reported Q4 rev of $34.5 mln, double last year's figure, citing strong momentum in voice-enabled Agentic AI** Analysts expected rev of $33.8 mln, according to LSEG data** Co raised 2025 rev outlook to $157-$177 mln, up from prior forecast of $155-$175 mln** DA Davidson reiterated 'buy' rating and hiked PT from $9.50 to $13** Demand remains elevated as SOUN expands its business with leading players across industries including financial, healthcare, energy and others, DA Davidson said in note** 6 of 7 brokerages rate SOUN \"strong buy\" or \"buy\", 1 rates \"hold\"; median PT of $13 up from $9 a month ago - LSEG** Through Thurs, stock down ~54%. AI-related names have been pressured since Chinese startup DeepSeek rolled out a free AI model a month ago","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL6N3PJ0IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOUN","BK4587","BK4608","BK4547","BK4023","BK4609"],"gpt_icon":1}],"pageSize":16,"totalPage":10,"pageCount":6,"totalSize":157}]}}